138 related articles for article (PubMed ID: 21510634)
1. Novel positive allosteric modulators of the human α7 nicotinic acetylcholine receptor.
Arias HR; Gu RX; Feuerbach D; Guo BB; Ye Y; Wei DQ
Biochemistry; 2011 Jun; 50(23):5263-78. PubMed ID: 21510634
[TBL] [Abstract][Full Text] [Related]
2. Different interaction between the agonist JN403 and the competitive antagonist methyllycaconitine with the human alpha7 nicotinic acetylcholine receptor.
Arias HR; Gu RX; Feuerbach D; Wei DQ
Biochemistry; 2010 May; 49(19):4169-80. PubMed ID: 20377277
[TBL] [Abstract][Full Text] [Related]
3. Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.
Arias HR; López JJ; Feuerbach D; Fierro A; Ortells MO; Pérez EG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2420-30. PubMed ID: 23954208
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes.
Arias HR; Feuerbach D; Targowska-Duda K; Kaczor AA; Poso A; Jozwiak K
Biochim Biophys Acta; 2015 Feb; 1848(2):731-41. PubMed ID: 25475645
[TBL] [Abstract][Full Text] [Related]
5. Differential pharmacological activity of JN403 between α7 and muscle nicotinic acetylcholine receptors.
Arias HR; De Rosa MJ; Bergé I; Feuerbach D; Bouzat C
Biochemistry; 2013 Nov; 52(47):8480-8. PubMed ID: 24164482
[TBL] [Abstract][Full Text] [Related]
6. Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula.
Arias HR; Jin X; Feuerbach D; Drenan RM
Int J Biochem Cell Biol; 2017 Nov; 92():202-209. PubMed ID: 29042244
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors.
Arias HR; Bhumireddy P; Spitzmaul G; Trudell JR; Bouzat C
Biochemistry; 2006 Feb; 45(7):2014-26. PubMed ID: 16475790
[TBL] [Abstract][Full Text] [Related]
8. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
Arias HR
Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
[TBL] [Abstract][Full Text] [Related]
9. Selectivity of (±)-citalopram at nicotinic acetylcholine receptors and different inhibitory mechanisms between habenular α3β4* and α9α10 subtypes.
Arias HR; Jin XT; Gallino S; Peng C; Feuerbach D; García-Colunga J; Elgoyhen AB; Drenan RM; Ortells MO
Neurochem Int; 2019 Dec; 131():104552. PubMed ID: 31545995
[TBL] [Abstract][Full Text] [Related]
10. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
[TBL] [Abstract][Full Text] [Related]
11. Temperature and ionic strength dependence of quinacrine binding and quinacrine displacement elicited by high concentrations of agonists on the nicotinic acetylcholine receptor.
Arias HR
Arch Biochem Biophys; 1996 Sep; 333(1):1-11. PubMed ID: 8806747
[TBL] [Abstract][Full Text] [Related]
12. In vitro pharmacological characterization of a novel allosteric modulator of alpha 7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profile.
Malysz J; Grønlien JH; Anderson DJ; Håkerud M; Thorin-Hagene K; Ween H; Wetterstrand C; Briggs CA; Faghih R; Bunnelle WH; Gopalakrishnan M
J Pharmacol Exp Ther; 2009 Jul; 330(1):257-67. PubMed ID: 19389923
[TBL] [Abstract][Full Text] [Related]
13. Drimane Sesquiterpenoids Noncompetitively Inhibit Human α4β2 Nicotinic Acetylcholine Receptors with Higher Potency Compared to Human α3β4 and α7 Subtypes.
Arias HR; Feuerbach D; Schmidt B; Heydenreich M; Paz C; Ortells MO
J Nat Prod; 2018 Apr; 81(4):811-817. PubMed ID: 29634269
[TBL] [Abstract][Full Text] [Related]
14. Positive and negative modulation of nicotinic receptors.
Arias HR
Adv Protein Chem Struct Biol; 2010; 80():153-203. PubMed ID: 21109220
[TBL] [Abstract][Full Text] [Related]
15. Noncompetitive antagonist binding sites in the torpedo nicotinic acetylcholine receptor ion channel. Structure-activity relationship studies using adamantane derivatives.
Arias HR; Trudell JR; Bayer EZ; Hester B; McCardy EA; Blanton MP
Biochemistry; 2003 Jun; 42(24):7358-70. PubMed ID: 12809491
[TBL] [Abstract][Full Text] [Related]
16. The subtype-selective nicotinic acetylcholine receptor positive allosteric potentiator 2087101 differentially facilitates neurotransmission in the brain.
de Filippi G; Mogg AJ; Phillips KG; Zwart R; Sher E; Chen Y
Eur J Pharmacol; 2010 Sep; 643(2-3):218-24. PubMed ID: 20624387
[TBL] [Abstract][Full Text] [Related]
17. Alkaloids Purified from
Arias HR; Ortells MO; Feuerbach D; Burgos V; Paz C
J Nat Prod; 2019 Jul; 82(7):1953-1960. PubMed ID: 31276409
[TBL] [Abstract][Full Text] [Related]
18. Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors.
Arias HR; Feuerbach D; Targowska-Duda KM; Russell M; Jozwiak K
Biochemistry; 2010 Jul; 49(27):5734-42. PubMed ID: 20527991
[TBL] [Abstract][Full Text] [Related]
19. Identification of regions involved in the binding of alpha-bungarotoxin to the human alpha7 neuronal nicotinic acetylcholine receptor using synthetic peptides.
Marinou M; Tzartos SJ
Biochem J; 2003 Jun; 372(Pt 2):543-54. PubMed ID: 12614199
[TBL] [Abstract][Full Text] [Related]
20. Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
Arias HR; Targowska-Duda KM; Feuerbach D; Jozwiak K
Int J Biochem Cell Biol; 2015 Aug; 65():81-90. PubMed ID: 26022277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
